Elation Health and Seoul Medical Group Collaborate to Enhance Primary Care Services Recently, clinical technology company Elation Health has announced a partnership with Seoul Medical Group Health, Inc. (SMG), the largest Korean-American independent practice association (IPA) in the United States. This collaboration will provide SMG's network of over 5,000 primary care physicians and specialists with Elation Health’s custom electronic health record (EHR) platform, designed to optimize patient care, enhance collaboration, and support clinical integration for better treatment outcomes. Under the agreement, SMG-affiliated primary care centers will benefit in four key areas: seamless digital integration with SMG and its entire medical network; tailored platform launch experiences and ongoing personalized support; competitive pricing for Elation's EHR; and workflows aligned with SMG's value-based care model, automating the submission of reports required by SMG to ensure high-quality care and recognition for providers. This partnership aims to improve the efficiency and coordination of care for attributed patient panels, especially focusing on comprehensive individual care and enhancing service quality for the elderly population. The platform will offer exclusive templates and workflows to simplify management processes and ensure accurate data transmission to SMG's systems. Kyna Fong, co-founder and CEO of Elation Health, emphasized the shared commitment to the future of independent physician practices and primary care. "By joining forces with SMG to advance value-based care, we will not only elevate the experience and sustainability of small-scale primary care practices but also lay the groundwork for a better future," she stated. Myong Lee, CEO of Advanced Medical Management, Inc., representing SMG, highlighted Elation EHR’s leadership in healthcare technology and its robust support for integrated care. "Together, we aim to achieve the quadruple aim in healthcare—better care, improved outcomes, lower costs, and enhanced patient experience," Lee remarked. Seoul Medical Group, established in 1993, is one of the leading physician-led IPAs in the U.S., featuring 4,800 doctors focused on both clinical and non-clinical health services. As a large network dedicated to the health and well-being of Asian Americans, SMG operates across multiple regions, serving over 100,000 patients. Elation Health, an award-winning and KLAS top-rated technology platform, supports 36,000 physicians in delivering high-quality care to more than 20 million Americans. Known for its user-centric AI-driven EHR and billing solutions, Elation Health has garnered high praise for its innovative collaboration, workflow, and AI implementations, making it a standout in the primary care sector. Industry experts view this collaboration as a significant step forward in the U.S. healthcare landscape. By integrating advanced EHR technology and efficient care coordination strategies, the partnership aims to enhance patient experiences and reduce the administrative burden on physicians, making primary care more effective and personalized. Anumana Secures Series C Funding to Expand Its AI-Driven Healthcare Solutions Leading AI-driven health technology company Anumana has recently completed a new series C funding round, attracting a major investment from Boston Scientific Corporation. This financial injection will support Anumana in expanding its ECG-AI™ technology from diagnostic applications to perioperative and acute cardiac care, accelerating the development of a multimodal generative AI platform, and advancing the commercialization of software as a medical device (SaMD) products. This round not only solidifies Anumana's position in AI cardiovascular diagnostics but also provides funding for clinical programs to generate real-world evidence on the early detection and effective intervention capabilities of ECG-AI™ in preventive cardiology. Anumana is developing innovative generative AI imaging and visualization technologies to enhance the precision and effectiveness of complex cardiac interventions. These technologies will include real-time imaging and predictive algorithms suitable for procedures like structural heart disease treatments, interventional cardiology, and electrophysiology surgeries. Specifically, Anumana and Boston Scientific will collaborate on electrophysiology surgery solutions for atrial fibrillation patients, including cardiac ablation and left atrial appendage closure. These tools will seamlessly integrate into clinical workflows, offering new methods for intraoperative decision support and enabling doctors to interpret complex data more intuitively for faster treatment decisions. Maulik Nanavaty, CEO of Anumana, expressed excitement about the investment. "This new funding recognizes our strategic direction and momentum. We have built a strong foundation in AI-driven diagnostic cardiology and are now poised to extend into perioperative care. By applying generative AI to imaging and intraoperative support, we are creating user-friendly products that can process complex data in real-time and enhance care delivery." Anumana's multimodal AI system leverages nference's platform and millions of anonymized patient longitudinal data to offer innovative tools for early diagnosis, intraoperative decision support, and optimized workflows. The company aims to develop AI cardiac tools that can be seamlessly integrated into daily medical practice, breaking down existing standards of care and improving patient outcomes. Anumana's ECG-AI™ LEF algorithm has already received FDA approval and will be eligible for reimbursement in the U.S. starting January 2025. The company is committed to developing technologies that significantly enhance the care experience for cardiovascular patients. Experts in the field believe Anumana's multimodal AI technology represents a revolutionary change in cardiology, particularly its potential applications in perioperative care. Support from Mayo Clinic and nference gives Anumana unique advantages in data access and algorithm development. With continuous technological advancements, Anumana is expected to play a crucial role in improving the quality of life for patients with heart conditions. WellSky and StoneGate Senior Living Partner to Transform Elderly Care Global health and community care technology and service company WellSky has announced a new partnership with StoneGate Senior Living, a leading provider of elderly care services in the United States. This collaboration demonstrates StoneGate's commitment to using technology to enhance the quality of care and operational efficiency for residents. StoneGate operates over 30 skilled nursing, rehabilitation centers, assisted living communities, and memory care facilities in Texas, Oklahoma, and Colorado. Previously, StoneGate used WellKy’s CarePort Intake solution to manage referral processes with hospital partners. To further modernize its IT infrastructure, StoneGate has chosen WellSky Long-Term Care as its EHR and revenue cycle management platform. John Paul Taylor, CEO of StoneGate Senior Living, underscored the importance of partnering with a forward-thinking technology innovator. "We want to collaborate with a company that continues to meet the cutting-edge needs of our industry. WellSky’s willingness to align our processes with their technology ensures that the solutions will be effective for us." WellSky's long-term care solution covers critical aspects of resident care before, during, and after admission. The platform integrates clinical care and revenue cycle management functions, streamlining operations and reducing complexity to enhance care quality. WellSky's technology will enable StoneGate’s team to make more informed data-driven decisions, lighten administrative loads, improve care coordination, and deliver better outcomes for residents while significantly boosting operational efficiency. Moreover, StoneGate will actively participate in the development of the WellSky Long-Term Care solution, providing regular feedback to the WellSky team. They will also collaborate on several new features driven by SkySense AI, a set of AI-based tools designed to optimize care processes through data analysis. Bill Miller, founder and CEO of WellSky, highly commended the partnership. "This collaboration exemplifies the synergies between a visionary care provider like StoneGate and a technology leader like WellSky, creating greater value for residents, care teams, and leaders throughout the industry. Our platform will help StoneGate address current challenges and set new benchmarks for innovation in long-term care." Industry analysts see this partnership as indicative of a growing trend where advanced technology is integrated with medical care to modernize elderly care services. With WellSky's extensive client base and technological prowess, StoneGate stands to gain unprecedented opportunities for improvement. This collaboration will also solidify StoneGate's market position as a provider of high-standard care services. WellSky, with its 40 years of industry experience, continues to pioneer innovative products that enable various healthcare institutions to deliver more efficient and higher-quality care. Claritev and Claims Care Revenue Cycle Management Align to Enhance RCM in MENA Claritev, a U.S.-based company, and Claims Care Revenue Cycle Management (CCRCM), a subsidiary of Berjeel Holding in Dubai, have signed a memorandum of understanding (MoU) to introduce Claritev’s technology solutions to the Middle East and North Africa (MENA) region and collaborate on developing advanced revenue cycle management (RCM) capabilities. By pooling resources, expertise, and regional networks, both companies aim to create transformative RCM products that leverage Claritev’s advanced coding and decision science technologies, combined with CCRCM’s deep RCM experience and regional leadership, to streamline the medical claims reimbursement process. According to the MoU terms, Claritev and CCRCM will jointly develop innovative RCM solutions to improve the efficiency, transparency, and quality of medical claims reimbursements, thereby enhancing healthcare services. The partnership also involves shifting certain offshoring business processes to CCRCM to strengthen operational synergy and market alignment. John Suniil, CEO of Berjeel Holding, highlighted the significance of the collaboration. "At Berjeel Holding, we strive to enhance healthcare quality through innovation and strategic alliances. Partnering with Claritev marks a vital step in transforming RCM in the MENA region. By integrating Claritev’s cutting-edge technology and CCRCM’s extensive expertise, we will drive efficiency, transparency, and value across the healthcare system." Travis Dalton, chairman and CEO of Claritev, stated, "The global healthcare industry is at a turning point, and we aim to revolutionize it through technology and data." He added, "Claims Care Revenue Cycle Management, being one of the largest RCM service providers in the Middle East, shares a common vision with Claritev—providing innovative solutions to the entire healthcare ecosystem to make healthcare more accessible and affordable." Claritev, led by a team with extensive innovation and experience, has developed a robust enterprise platform utilizing more than 40 years of claims data. The platform incorporates advanced AI technology to offer deep data insights, support network optimization and benefits design, and improve the affordability and price transparency of healthcare services. It provides customized solutions for payers, employers, patients, healthcare providers, and third parties to make healthcare more accessible and cost-effective. Founded in 2016, CCRCM belongs to Berjeel Holding, a leading super-specialty healthcare provider in the MENA region and a listed company on the Abu Dhabi Securities Exchange. CCRCM employs 1,000 staff and operates multiple centers globally, processing complex billing and claims management. Currently, the company manages over 3.5 million records, 5.4 million claims, and 1,500 major contracts, offering comprehensive solutions from patient registration to claims reimbursement, along with additional services such as medical transcription, business and revenue intelligence analysis, and quality assurance audits. Industry insiders view this partnership as beneficial in strengthening healthcare services in the MENA region, reflecting a trend among medical technology companies to form local collaborations for optimizing business models on a global scale. Berjeel Holding, as a leading healthcare service provider in the region, will further consolidate its market leadership through this collaboration. Perfect Corp. Enhances AIREM's Patient Experience with AI Skincare Technology Global leader in AR and AI beauty and fashion technology, Perfect Corp., has announced a collaboration with AIREM, a premium aesthetic brand founded by Dr. Eunice Park. This partnership aims to revolutionize patient care experiences in aesthetic health by integrating Perfect Corp.’s Skincare Pro technology. Skincare Pro uses artificial intelligence to conduct multi-dimensional skin analysis, generating detailed reports on various skin conditions, including texture, imperfections, and wrinkles. The collaboration will help AIREM deliver more scientific and effective treatment services. Skincare Pro’s deep learning algorithms assess patients' skin conditions accurately, providing clear, visual data support that makes it easier for patients to understand their skin. Additionally, the technology recommends the most suitable skincare products and treatment plans based on individual patient data, enhancing the personalized aspect of the patient experience. Dr. Eunice Park, founder of AIREM, expressed enthusiasm about the integration: "We are thrilled to incorporate Perfect Corp.'s Skincare Pro technology, ensuring our patients receive precise and personalized care, leading to significant improvements in their skin health." Alya Chen, CEO of Perfect Corp., added, “We are honored to partner with AIREM to push the boundaries of technological advancement in the aesthetic health industry.” This partnership signifies a critical evolution in medical aesthetics, demonstrating how technology can be leveraged to improve patient satisfaction and treatment outcomes. As consumer demand for high-quality medical services grows, AI-driven technologies like those provided by Perfect Corp. are becoming essential tools for enhancing the overall patient experience. Industry experts agree that this collaboration sets a precedent for other medical aesthetics organizations to follow, illustrating the potential of integrating advanced technology to elevate patient satisfaction and care results. It represents a step towards a future where innovative AI solutions play a pivotal role in the medical aesthetics sector.